Park Ha Biological Technology Co. Ltd. Ordinary Shares
BYAH | NASDAQ
$2.55
+$0.10 (+4.08%)
Sep 22, 2026, 10:56 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Apr 29, 2026 | Q1 2026 Jan 30, 2026 | Q4 2025 Oct 30, 2025 | Q3 2025 Jul 30, 2025 | Q2 2025 Apr 29, 2025 |
|---|---|---|---|---|---|
Revenue | 1.26M | 628.85K | 1.29M | 642.82K | 1.24M |
Cost of Revenue | 141K | 22.86K | 177.89K | 42.01K | 58.5K |
Gross Profit | 1.12M | 605.99K | 1.11M | 600.81K | 1.18M |
Operating Income | -962.55K | -481.27K | -4.43M | -2.22M | -19.72M |
Interest Income | 49.49K | n/a | 5.68K | n/a | 416 |
Pretax Income | -929.5K | -464.75K | -4.43M | -2.21M | -19.66M |
Net Income | -918.28K | -459.14K | -4.53M | -2.26M | -19.84M |
Selling & General & Admin | 1.94M | 1.02M | 5.33M | 2.71M | 20.87M |
Research & Development | 138.62K | 69.31K | 212.1K | 106.05K | 26.09K |
Other Expenses | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 2.08M | 1.09M | 5.54M | 2.82M | 20.9M |
Interest Expense | 4 | n/a | 21 | n/a | 20 |
Selling & Marketing Expenses | n/a | 280.29K | n/a | 197.76K | n/a |
Cost & Expenses | 2.22M | 1.11M | 5.72M | 2.86M | 20.95M |
Income Tax Expense | -11.22K | 5.61K | 101.7K | 50.85K | 178.95K |
Shares Outstanding (Basic) | 4.92M | 2.8M | 594.98K | 639.99K | 587.49K |
Shares Outstanding (Diluted) | 4.92M | 2.8M | 594.98K | 639.99K | 587.49K |
EPS (Basic) | -0.19 | -0.16 | -7.61 | -3.54 | -33.76 |
EPS (Diluted) | -0.19 | -0.16 | -7.61 | -3.54 | -33.76 |
EBITDA | -867.27K | -433.63K | -4.33M | -2.17M | -19.64M |
EBIT | -962.55K | -481.27K | -4.43M | -2.22M | -19.66M |
Depreciation & Amortization | 95.28K | 47.64K | 93.86K | 46.93K | 15.51K |
Add to Watchlist
Select watchlists to add or remove BYAH